Generating AI analysis...
AI Earnings Analysis
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Revenue | $695.4M | $716.6M | -2.96% |
Cost of Revenue | $465.2M | $445.3M | +4.47% |
Gross Profit | $230.2M | $271.3M | -15.15% |
Operating Income | $122.8M | $155.3M | -20.93% |
Net Income | $115.3M | $140M | -17.64% |
EPS (Basic) | $1.57 | $1.88 | -16.49% |
EPS (Diluted) | $1.55 | $1.85 | -16.22% |
R&D Expense | $17.6M | $17.1M | +2.92% |
SG&A Expense | $86.7M | $86M | +0.81% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Total Assets | $3.6B | $3.72B | -3.26% |
Current Assets | $1.69B | $1.94B | -12.61% |
Total Liabilities | $921.7M | $947.4M | -2.71% |
Current Liabilities | $648.4M | $534.9M | +21.22% |
Stockholders' Equity | $2.68B | $2.78B | -3.44% |
Cash & Equivalents | $601.8M | $886.3M | -32.10% |
Long-Term Debt | $206.2M | $208.3M | -1.01% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Operating Cash Flow | $118.2M | $138.1M | -14.41% |
Investing Cash Flow | $-90.6M | $-82.1M | -10.35% |
Financing Cash Flow | $-271M | $-71M | -281.69% |
Share Buybacks | $267M | $60.1M | +344.26% |
D&A | $35.6M | — | — |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Gross Margin | 33.1% | 37.9% | -4.76% |
Operating Margin | 17.7% | 21.7% | -4.01% |
Net Margin | 16.6% | — | — |
ROE | 4.3% | — | — |
ROA | 3.2% | — | — |
Current Ratio | $2.611 | — | — |
Debt to Equity | $0.344 | — | — |
Other companies in Life Sciences Tools & Services